HCA Forecast, price target & analysts
HCA Target price 2025 - Analyst rating & recommendation
HCA Classifications & Recommendation:
HCA Price Target
| Target Price | $376.05 |
| Price | $353.92 |
| Potential |
6.25%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target HCA 2026 .
The average HCA target price is $376.05.
This is
6.25%
register free of charge
$438.00
23.76%
register free of charge
$320.00
9.58%
register free of charge
|
|
| A rating was issued by 27 analysts: 16 Analysts recommend HCA to buy, 10 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the HCA stock has an average upside potential 2026 of
6.25%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 70.60 | 74.62 |
| 8.67% | 5.69% | |
| EBITDA Margin | 19.63% | 19.84% |
| 0.38% | 1.07% | |
| Net Margin | 7.57% | 8.25% |
| 6.77% | 8.97% |
21 Analysts have issued a sales forecast HCA 2025 . The average HCA sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an HCA EBITDA forecast 2025. The average HCA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 HCA Analysts have issued a net profit forecast 2025. The average HCA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 22.00 | 25.34 |
| 16.03% | 15.18% | |
| P/E | 13.97 | |
| EV/Sales | 1.79 |
10 Analysts have issued a HCA forecast for earnings per share. The average HCA EPS is
This results in the following potential growth metrics and future valuations:
Current HCA Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Apr 15 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jan 27 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jan 27 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Jan 27 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jan 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 28 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Apr 15 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jan 27 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jan 27 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jan 27 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jan 27 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
